Well Care Compounding Pharmacy Issues Recall
The company recalls products due to sterility concerns.
FDA announced on May 17, 2016 that Well Care Compounding Pharmacy (Las Vegas, NV) is voluntarily recalling sterile compounded products distributed between Jan. 1–April 29, 2016. The recall comes after an FDA inspection of the facility that resulted in sterility assurance concerns.
The company states in a press release that it has not received any adverse events related to the products, as of May 17. However, because administration of a sterile product that may be compromised could result in serious infections or death, the company is advising customers to stop using the recalled products.
Source: FDA
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
